![Ashraf Amanullah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Ashraf Amanullah is currently Chief Technical Operations Officer & Executive VP at Inhibrx Biosciences, Inc. Formerly, Dr. Amanullah was Chief Technical Operations Officer & Executive VP at Sanofi AATD, Inc. from 2018 to 2024, Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018, Senior Director at Gilead Sciences, Inc. from 2011 to 2015, and Director-Process Development at Genentech, Inc. from 2006 to 2011.
Dr. Amanullah earned a doctorate from the University of Birmingham.
Cargos activos de Ashraf Amanullah
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Ashraf Amanullah.
| Empresas | Cargo | Fin |
|---|---|---|
| INHIBRX, INC. | Director Técnico/Científico/I+D | 30/05/2024 |
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/07/2018 |
| GILEAD SCIENCES, INC. | Director/Miembro de la Junta | 01/08/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2011 |
Formación de Ashraf Amanullah.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
81
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Ashraf Amanullah
Elige MarketScreener 
